Dian Diagnostics Group (300244.SZ) Earnings Analysis
Dian Diagnostics Group (300244.SZ) next reports earnings on 2026-08-21, consensus EPS 0.19 CNY. Last quarter (2026-04-22) it beat with EPS -0.0207 CNY vs -0.04 CNY est (+48.3%). It has beaten estimates in 1/4 recent quarters (25%). Trailing P/E 76.26.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 300244.SZ next report earnings?
| Next earnings date | 2026-08-21 |
|---|---|
| Consensus EPS estimate | 0.19 CNY |
| Revenue estimate | 2.63B |
300244.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-22 | -0.0207 CNY | -0.04 CNY | +48.3% | Beat |
| 2025-10-24 | 0.07597 CNY | 0.09 CNY | -15.6% | Miss |
| 2025-04-28 | -0.03 CNY | 0.2 CNY | -115% | Miss |
| 2024-08-23 | 0.08 CNY | 0.28 CNY | -71.4% | Miss |
Beat rate: 1/4 (25%) over reported quarters with consensus data.
300244.SZ valuation and analyst view
| Trailing P/E | 76.26 |
|---|---|
| Trailing EPS | 0.2118 CNY |
| Price / book | 1.55 |
| Dividend yield | 2.12% |
| Market cap | 10.75B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Dian Diagnostics Group (300244.SZ)'s next earnings date?
Dian Diagnostics Group is next scheduled to report on 2026-08-21, with a consensus EPS estimate of 0.19 CNY and revenue estimate of 2.63B.
Did 300244.SZ beat earnings last quarter?
In its 2026-04-22 report, 300244.SZ posted EPS of -0.0207 CNY versus a -0.04 CNY estimate — a beat of 48.3%.
What is 300244.SZ's earnings track record?
Over the last 4 reported quarters with consensus data, 300244.SZ beat estimates 1 times (25%).
What is 300244.SZ's current P/E ratio and EPS?
300244.SZ trades at a trailing P/E of 76.26 on trailing EPS of 0.21180275807029217 CNY.
What do analysts rate 300244.SZ?
300244.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.